| 1 | [SID49644842] | Active | EC50 | 0.125 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Active | | EC50 | 0.125 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID49644842] | Active | Potency | 10 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 3 | [SID49644842] | Active | EC50 | 20.195 | Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. [AID2010, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Active | | EC50 | 20.195 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. | | AID | 2010 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID49644842] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID49644842] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID49644842] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID49644842] | Active | | | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication [AID1885, Type: screening] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Active | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication | | AID | 1885 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID49644842] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 9 | [SID49644842] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 10 | [SID49644842] | Inactive | Potency | 19.9526 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 11 | [SID49644842] | Inactive | Potency | | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 12 | [SID49644842] | Inactive | Potency | | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 13 | [SID49644842] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). [AID1861, Type: screening] | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). | | AID | 1861 | | BioAssay type | screening | | Target | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] | | PubMed | | | Data Table |  |
|
| 14 | [SID49644842] | Inactive | | | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). [AID1861, Type: screening] | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). | | AID | 1861 | | BioAssay type | screening | | Target | neuropeptides B/W receptor 1 [Homo sapiens] [gi:119607128] | | PubMed | | | Data Table |  |
|
| 15 | [SID49644842] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 16 | [SID49644842] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 17 | [SID49644842] | Inactive | IC50 | | Image-Based HTS for Selective Antagonists of GPR35 [AID2058, Type: confirmatory] | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Image-Based HTS for Selective Antagonists of GPR35 | | AID | 2058 | | BioAssay type | confirmatory | | Target | G-protein coupled receptor 35 isoform a [Homo sapiens] [gi:33695097] | | PubMed | | | Data Table |  |
|
| 18 | [SID49644842] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 19 | [SID49644842] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 20 | [SID49644842] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 21 | [SID49644842] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 22 | [SID49644842] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 23 | [SID49644842] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 24 | [SID49644842] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 25 | [SID49644842] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 26 | [SID49644842] | Inactive | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 27 | [SID49644842] | Inactive | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 28 | [SID49644842] | Inactive | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 29 | [SID49644842] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 30 | [SID49644842] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 31 | [SID49644842] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 32 | [SID49644842] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 33 | [SID49644842] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 34 | [SID49644842] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 35 | [SID49644842] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) [AID493087, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) | | AID | 493087 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 36 | [SID49644842] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 37 | [SID49644842] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 38 | [SID49644842] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 39 | [SID49644842] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 40 | [SID49644842] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 41 | [SID49644842] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 42 | [SID49644842] | Inactive | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 43 | [SID49644842] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 44 | [SID49644842] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 45 | [SID49644842] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 46 | [SID49644842] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 47 | [SID49644842] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 48 | [SID49644842] | Inactive | Potency | | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 49 | [SID49644842] | Inactive | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers [AID493056, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers | | AID | 493056 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|
| 50 | [SID49644842] | Inactive | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. [AID493084, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49644842 | | CID | 24747095 | | Outcome | Inactive | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. | | AID | 493084 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|